Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Folia Microbiologica|January 1, 1994
The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivoM Petrek, E Weigl, M OrdeltováActa Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Immunomodulatory effects of laser therapy in the treatment of chronic tonsillitisM Petrek, J Hubácek, M OrdeltováActa Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1992
Immunological profile of patients with recurrent respiratory infectionsJ Bystron, M Petrek, Z Hermanová, et al.Ceska Gynekologie|March 8, 2011
[Possibility to identify fetomaternal haemorrhage]M Studnicková, M L'ubuský, M Ordeltová, et al.Vnitrni Lekarstvi|October 25, 2000
[Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. I. Relation to selected laboratory indicators of the disease]V Scudla, M Ordeltová, A Spidlová, et al.Vnitrni Lekarstvi|August 1, 1996
[Determination of the bromodeoxyuridine index in multiple myeloma. II. Relation to level of advancement and disease activity]V Scudla, M Ordeltová, J Bacovský, et al.Vnitrni Lekarstvi|April 9, 2008
[Assessment of plasmatic cell proliferation and apoptosis indexes in the course of multiple myeloma]J Minarík, V Scudla, M Ordeltová, et al.Vnitrni Lekarstvi|August 22, 2000
[Relation of the soluble cytoadhesion molecules VCAM-1 and ICAM-1 to selected clinical and laboratory indicators in multiple myeloma]V Scudla, M Budíková, J Bacovský, et al.Vnitrni Lekarstvi|October 25, 2000
[Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. II. Relation to disease extent and activity]V Scudla, M Ordeltová, A Spidlová, et al.Vnitrni Lekarstvi|July 1, 1996
[The bromodeoxyuridine index in multiple myeloma. I. Relation with selected laboratory indicators of the disease]V Scudla, M Ordeltová, J Bacovský, et al.Pageof 2